Latest News - ResMed
Top Corporates Hub
ResMed
2 Healthcare Stocks to Research Further and 1 We Find Risky
23.05.2026 11:08
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 1.8% return has trailed the S&P 500 by 9 percentage points.
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access
20.05.2026 09:13
ResMed (RMD) is in focus after announcing a collaboration with Oura that connects Oura Ring users in the US to ResMed’s sleep education tools, assessments, and potential care pathways for obstructive sleep apnea. See our latest analysis for ResMed. The collaboration with Oura lands at a time when momentum in ResMed’s share price has cooled, with the stock down about 19.8% on a 90-day share price return and its 1-year total shareholder return down around 15.5%, even after a recent 1-week share...
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
12.05.2026 07:00
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend
09.05.2026 13:15
It looks like ResMed Inc. ( NYSE:RMD ) is about to go ex-dividend in the next four days. The ex-dividend date is...
10 Dividend Growth Stocks: May 2025
09.05.2026 09:00
Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases.
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
02.05.2026 17:48
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
ResMed Q3 Earnings Call Highlights
02.05.2026 10:35
ResMed (NYSE:RMD) reported third-quarter fiscal 2026 results highlighted by revenue growth, gross margin expansion, and higher non-GAAP earnings per share, while also announcing a CFO transition and a planned tuck-in acquisition to expand beyond its core sleep apnea business. Leadership updates: CF
RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment
02.05.2026 10:12
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 10.8% year on year to $1.43 billion. Its non-GAAP profit of $2.86 per share was 2.2% above analysts’ consensus estimates.
ResMed: Stock splutters, but machine is still breathing well
02.05.2026 09:59
ResMed delivered a quarter that was more robust than the market reaction suggests. The stock's decline of over 4% in after-hours trading on Thursday, following a dip to its lowest level since February...
Friday's session: gap up and gap down stock in the S&P500 index
01.05.2026 14:35
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Friday. Discover the gap up and gap down stocks in the S&P500 index.
RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
01.05.2026 12:02
Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across key segments.
ResMed Inc (RMD) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions
01.05.2026 07:18
ResMed Inc (RMD) reports an 11% revenue increase and strategic acquisition plans, while navigating supply chain challenges and competitive pressures.
ResMed: Stock coughs, but the machine is still breathing well
01.05.2026 05:00
ResMed delivered a stronger quarter than the market reaction suggests. The more than 4% drop in the stock after-hours yesterday, following a dip to its lowest level since February 2024, contrasts with...
ResMed Inc. Q3 2026 Earnings Call Summary
01.05.2026 00:47
Moby summary of ResMed Inc.'s Q3 2026 earnings call
Did Stronger Profit Forecasts and Sleep Apnea Tailwinds Just Shift ResMed's (RMD) Investment Narrative?
30.04.2026 09:07
Earlier this week, ResMed (NYSE:RMD) reported that it will release its quarterly earnings on Thursday afternoon, with Wall Street expecting around 10% year-on-year revenue growth and earnings of about US$2.79 per share on revenue near US$1.42 billion. At the same time, analysts and industry researchers highlight a growing global sleep apnea devices market, supported by rising diagnosis rates, technology improvements in CPAP and BiPAP devices, and increasing use of homecare and telemedicine...
Is It Time To Reassess ResMed (RMD) After Recent Share Price Weakness
25.04.2026 06:07
If you are wondering whether ResMed at around US$219.85 is starting to look like value or still pricing in a lot of optimism, you are in the right place. The share price has had a mixed run, with a 3.6% decline over the last 7 days, a 2.9% decline over 30 days, and returns of 10.2% lower year to date and 6.0% lower over the last year, even though the 5 year return sits at 22.1%. That pattern of pressure over shorter periods alongside a positive 5 year result can leave investors questioning...
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
23.04.2026 14:00
ResMed (RMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Resmed's Q3 Earnings on Deck: What's in Store for the Stock?
23.04.2026 13:09
RMD gears up for fiscal Q3 earnings with steady estimates, rising demand in sleep devices and AI-driven digital health tools poised to shape results.
Long-Term Care and Home Healthcare Global Market Analysis and Technology Research Report 2026-2030, Profiles of Leading Players - Baxter, Medtronic, Koninklijke Philips, ResMed, Sunrise Medical
23.04.2026 09:49
The aging population and prevalence of chronic diseases drive opportunities in long-term care and home healthcare technologies. Key growth areas include assistive living, rehabilitation, remote care, and monitoring. Regions like North America and Asia-Pacific present significant demand, with sustainability and ESG factors influencing advancements. Technologies for Long-Term Care and Home Healthcare Market Technologies for Long-Term Care and Home Healthcare Market Dublin, April 23, 2026 (GLOBE NE
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income
14.04.2026 09:51
ResMed Inc. offers a sustainable dividend with a 10-year growth history, backed by strong profitability, a low payout ratio, and a rock-solid balance sheet for durable passive income.